• Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Rating of "Moderate Buy" from Analysts

    来源: Buzz FX / 07 10月 2024 03:26:10   America/New_York


    Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat October 7, 2024 Share Link copied to clipboard. Shares of Apellis Pharmaceuticals, Inc.
    Read more...
分享